Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for GADOBENATE DIMEGLUMINE
- Study of 18F-FFNP Breast PET/MRI
- Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases
- PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions
- Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS
- Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
- P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
- PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma
- Retrospective Study of MRI in Pediatric Patients
- Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration
- Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients
- Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries
- Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar)
- Multihance at 3 Tesla (3T) in Brain Tumors
- Safety and Efficacy of MultiHance in Pediatric Patients
Clinical trials list
click for details